Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 3 , Pages 313-326 , June 2010

Anaesthesia for the obstetric patient with (non-obstetric) systemic disease

  • Peter J.W. Reide, MA, MBBS, FRCA (Fellow)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 8746 8026; Fax: +44 20 7117 1935.
    • ,
  • Steve M. Yentis, BSc, MBBS, FRCA, MD, MA (Consultant)

References 

  1. Harrison DA, Penny JA, Yentis SM, et al. Case mix, outcome and activity for obstetric admissions to adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Critical Care. 2005;9(Suppl. 3):S25–S37
  2. Saravanakumar K, Davies L, Lewis M, et al. High dependency care in an obstetric setting in the UK. Anaesthesia. 2008;63:1081–1086
  3. Zwart JJ, Richters JM, Ory F, et al. Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371,000 pregnancies. Br J Obstet Gynaecol. 2008;115:842–850
  4. Why Mothers Die . Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1997-1999. London: RCOG Press; 2001;
  5. Why Mothers Die . Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 2002-2004. London: RCOG Press; 2004;
  6. In:  Lewis G editors. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer- 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH; 2007;
  7. Malhotra S, Yentis SM. Reports on confidential enquiries into maternal deaths: management strategies based on trends in maternal cardiac deaths over 30 years. Int J Obstet Anesth. 2006;15:223–226
  8. Lupton M, Oteng-Ntim E, Ayida G, et al. Cardiac disease in pregnancy. Curr Opin Obstet Gynecol. 2002;14:137–143
  9. Burt CC, Durbridge J. Management of cardiac disease in pregnancy. Cont Edu Anaesth Crit Care Pain. 2009;9:44–47
  10. Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(Suppl. 3):627S–644S
  11. Montoya ME, Karnath BM, Masood A. Endocarditis during pregnancy. South Med J. 2003;96:1156–1157
  12. NICE Clinical Guidance 64 . Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. London: National Institute for Health and Clinical Excellence; 2008;www.nice.org.uk/Guidance/CG64
  13. Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis: Guidelines From the American Heart Association: A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–1754
  14. Weis FR, Markello R, Mo B, et al. Cardiovascular effects of oxytocin. Obstet Gynecol. 1975;46:211–214
  15. Yentis SM, Dob D. Anaesthesia for Caesarean section in patients with aortic stenosis. Anaesthesia. 1998;53:606–607
  16. Bolton T, Randall K, Yentis SM. Effect of the confidential enquiries into maternal deaths on the use of syntocinon at caesarean section in the UK. Anaesthesia. 2003;58:277–279
  17. Whitfield A, Holdcroft A. Anaesthesia for caesarean section in patients with aortic stenosis: the case for general anaesthesia. Anaesthesia. 1998;53:109–112
  18. Boyle RK. Anaesthesia in parturients with heart disease: a five year review in an Australian tertiary hospital. Int J Obstet Anesth. 2003;12:173–177
  19. Dob DP, Yentis SMUK. Registry of high-risk obstetric anaesthesia: report on cardiorespiratory disease. Int J Obstet Anesth. 2001;10:267–272
  20. Lewis N, Dob DP, Yentis SMUK. Registry of high-risk obstetric anaesthesia: arrhythmias, cardiomyopathy, aortic stenosis, transposition of the great arteries and Marfan's syndrome. Int J Obstet Anesth. 2003;12:28–34
  21. Oakley C. Management of labour and delivery in the high risk patient. In:  Oakley C editors. Heart disease in pregnancy. London: BMJ Publishing Group; 1997;p. 375–379
  22. Yentis S, Gatzoulis MA, Steer P. Pregnancy and coarctation of the aorta. J R Soc Med. 2003;96:471
  23. Suntharalingam G, Dob D, Yentis SM. Obstetric epidural analgesia in aortic stenosis: a low-dose technique for labour and instrumental delivery. Int J Obstet Anesth. 2001;10:129–134
  24. Kee WD, Shen J, Chiu AT, et al. Combined spinal epidural analgesia in the management of labouring parturients with mitral stenosis. Anaesth Intens Care. 1999;27:523–526
  25. Van de Velde M, Budts W, Vandermeersch E, et al. Continuous spinal analgesia for labor pain in a parturient with aortic stenosis. Int J Obstet Anesth. 2003;12:51–54
  26. Kwon HL, Belanger K, Bracken MB. Effect of pregnancy and stage of pregnancy on asthma severity: a systematic review. Am J Obstet Gynecol. 2004;190:1201–1210
  27. Gillet D, de Braekeleer M, Bellis G, et al. Cystic fibrosis and pregnancy. Report from French data (1980–1999). Br J Obstet Gynaecol. 2002;109:912–918
  28. Kwon H, Belanger K, Bracken M. Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from National Health Surveys. Ann Epidemiol. 2003;317–324vol
  29. Murphy VE, Gibson P, Talbot PI, et al. Severe asthma exacerbations during pregnancy. Obstet Gynecol. 2005;106:1046–1054
  30. Schatz M, Dombrowski MP. Asthma in pregnancy. N Engl J Med. 2009;360:1862–1869
  31. Rey E, Boulet LP. Asthma in pregnancy. BMJ. 2007;334:582–585
  32. Towers CV, Briggs GG, Rojas JA. The use of prostaglandin E2 in pregnant patients with asthma. Am J Obstet Gynecol. 2004;190:1777–1780
  33. National asthma education program report of the working group on asthma and pregnancy: management of asthma during pregnancy. Bethesda, MD: National Heart, Lung, and Blood Institute; September 1993;NIH publication no. 93-3279
  34. McMullen AH, Pasta DJ, Frederick PD, et al. Impact of pregnancy on women with cystic fibrosis. Chest. 2006;129:706–711
  35. Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005 Oct;33(10 Suppl):S390–S397
  36. May AE, Fombon FN, Francis S. UK Registry of High-risk Obstetric Anaesthesia: report on neurological disease. Int J Obstet Anesth. 2008;17:31–36
  37. Rutherford JM, Rubin PC. Management of epilepsy in pregnancy: therapeutic aspects. Br J Hosp Med. 1996;55:620–622
  38. Walker SP, Permezel M, Berkovic SF. The management of epilepsy in pregnancy. Br J Obstet Gynaecol. 2009;116:758–767SF
  39. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998;339:285–291
  40. Lee M, O'Brien P. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008;79:1308–1311
  41. Argov Z, Wirguin I. Drugs and the neuromuscular junction: pharmacotherapy of transmission disorders and drug-induced myasthenic syndromes. In:  Lisak RP editors. Handbook of Myasthenia Gravis and Myasthenic syndromes. 1994;p. 295–319
  42. Smith C, Bush GH. Anaesthesia and progressive muscular dystrophy. Br J Anaesth. 1985;57(11):pp. 1113–1111
  43. O'Connor PJ, Caldicott LD, Braithwaite P. Urgent caesarean section in a patient with myotonic dystrophy: a case report and review. Int J Obstet Anesth. 1996;5:272–274
  44. Yentis SM. Suxamethonium and hyperkalaemia. Anaesth Intensive Care. 1990;18:92–101
  45. Hilt H, Gramm HJ, Link J. Changes in intracranial pressure associated with extradural anaesthesia. Br J Anaesth. 1986;58:676–680
  46. Ruppen W, Derry S, McQuay H, et al. Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia/anesthesia. Anesthesiology. 2006;105:394–399
  47. Cook TM, Counsell D, Wildsmith JA. Royal College of Anaesthetists Third National Audit Project. Major complications of neuraxial blockade in the UK: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth. 2009;102:179–190
  48. Shehata N, Burrows R, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol. 1999;42:327–334
  49. Ramanathan J, Sibai BM, Vu T, et al. Correlation between bleeding times and platelet counts in women with preeclampsia undergoing cesarean section. Anesthesiology. 1989;71:188–191
  50. Beilin Y, Arnold I, Hossain S. Evaluation of the platelet function analyzer (PFA-100®) vs. the thromboelastogram (TEG) in the parturient. Int J Obstet Anesth. 2006;15:7–12
  51. Douglas MJ. Platelets, the parturient and regional anesthesia. Int J Obstet Anesth. 2001;10:113–120
  52. Bolton-Maggs PH. Bleeding problems in factor IX deficient women. Haemophilia. 1999;5:155–159
  53. Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol. 1998;105:314–321
  54. Drife J. Thromboembolism: Reducing maternal death and disability during pregnancy. Br Med Bull. 67: 177–190.
  55. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172–197
  56. Villers MS, Jamison MG, De Castro LM, et al. Morbidity associated with sickle cell disease in pregnancy. Am J Obstet Gynecol. 2008;199:125.e1–125.e5
  57. Finer P, Blair J, Rowe P. Epidural analgesia in the management of labor pain and sickle cell crisis–a case report. Anesthesiology. 1988;68:799–800
  58. de Man YA, Dolhain RJ, van de Geijn FE, et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241–1248
  59. Nicholson G, Burrin JM, Hall GM. Peri-operative steroid supplementation. Anaesthesia. 1998;53:1091–1104
  60. Clowse MEB, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199:127.e1–127.e6
  61. Younker D, Harrison B. Scleroderma and pregnancy, anaesthetic considerations. Br J Anaesth. 1985;57(11):1136–1139
  62. Schelew BL, Vaghadia H. Ankylosing spondylitis and neuraxial anaesthesia—a 10 year review. Can J Anesth. 1996;43:65–68
  63. Boinpally T, Jovanovic L. Management of type 2 diabetes and gestational diabetes in pregnancy. Mt Sinai J Med. 2009;76:269–280
  64. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30:S251–S260
  65. NICE Guideline 63 . Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. National Institute for Health and Clinical Excellence; 2008;www.nice.org.uk/Guidance/CG63
  66. Re C (Adult: Refusal of Treatment) [1994] 1 WLR 290.
  67. Re MB (An Adult: Medical Treatment) [1997] 38 BMLR 175 CA.
  68. Ludlow JP, Evans SF, Hulse G. Obstetric and perinatal outcomes in pregnancies associated with illicit substance abuse. Aust NZ J Obstet Gynaecol. 2004;44:302–306
  69. Ludlow J, Christmas T, Paech MJ, et al. Drug abuse and dependency during pregnancy: anaesthetic issues. Anaesth Intens Care. 2007;35:881–893
  70. Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–394

PII: S1521-6934(09)00151-5

doi: 10.1016/j.bpobgyn.2009.11.012

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 3 , Pages 313-326 , June 2010

Article Tools